Dr. Gregory Cote, MD
Claim this profileMassachusetts General Hospital
Studies Soft Tissue Sarcoma
Studies Uterine Tumors
19 reported clinical trials
27 drugs studied
Area of expertise
1Soft Tissue Sarcoma
Stage IV
Stage III
archival tumor tissue
2Uterine Tumors
Stage IV
TAZ-CAMTA1 positive
YAP1-TFE3 positive
Affiliated Hospitals
Clinical Trials Gregory Cote, MD is currently running
Nivolumab + Ipilimumab
for Childhood Cancers
This study is evaluating whether two immunotherapy drugs may be effective for treating certain types of cancer.
Recruiting1 award Phase 28 criteria
Peposertib + Tuvusertib
for Advanced Cancer
This phase I trial tests the safety, side effects and best dose of peposertib (M3814) in combination with tuvusertib (M1774) in treating patients with solid tumors that have spread to other places in the body (advanced). Peposertib and tuvusertib stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.
Recruiting1 award Phase 1
More about Gregory Cote, MD
Clinical Trial Related6 years of experience running clinical trials · Led 19 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Gregory Cote, MD has experience with
- Lurbinectedin
- Nivolumab
- Peposertib
- Tuvusertib
- Eribulin
- Doxorubicin
Breakdown of trials Gregory Cote, MD has run
Soft Tissue Sarcoma
Uterine Tumors
Cancer
Solid Tumors
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Gregory Cote, MD specialize in?
Gregory Cote, MD focuses on Soft Tissue Sarcoma and Uterine Tumors. In particular, much of their work with Soft Tissue Sarcoma has involved Stage IV patients, or patients who are Stage III.
Is Gregory Cote, MD currently recruiting for clinical trials?
Yes, Gregory Cote, MD is currently recruiting for 2 clinical trials in Boston Massachusetts. If you're interested in participating, you should apply.
Are there any treatments that Gregory Cote, MD has studied deeply?
Yes, Gregory Cote, MD has studied treatments such as Lurbinectedin, Nivolumab, Peposertib.
What is the best way to schedule an appointment with Gregory Cote, MD?
Apply for one of the trials that Gregory Cote, MD is conducting.
What is the office address of Gregory Cote, MD?
The office of Gregory Cote, MD is located at: Massachusetts General Hospital, Boston, Massachusetts 02114 United States. This is the address for their practice at the Massachusetts General Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.